BREAKING
Home » Posts Tagged "norovirus vaccine"

Norovirus: Vaxart’s oral vaccine met all primary/secondary endpoints in Phase 1b study

By

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced positive topline results from the randomized,...

Norovirus: UNC breakthrough brings us closer to a vaccine

By

Researchers at the University of North Carolina at Chapel Hill Gillings School of Global Public Health and their colleagues at the University of Texas at Austin and the National Institutes of Health Vaccine...

Oral norovirus vaccine to enter Phase 1b trial

By

The bivalent Norovirus GII.4 oral tablet vaccine developed by Vaxart is moving forward–the initiation of a Phase 1b clinical trial. “The initiation of the bivalent norovirus vaccine Phase 1b trial...

Norovirus vaccine: Oral tablet Phase 1 clinical trial results published

By

Vaxart, Inc. a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced publication of the comprehensive results of...

Norovirus tablet vaccine shows positive results in Phase 1 study

By

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced Tuesday that its norovirus tablet vaccine met...

Oral norovirus vaccine clinical trials to begin

By

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced Tuesday the initiation of a Phase 1 clinical...

Norovirus: Takeda vaccine candidate in human clinical trials

By

Takeda Pharmaceutical Company Limited today announced that it has dosed the first subject in a Phase 2b field efficacy trial of Takeda’s norovirus vaccine candidate (TAK-214), the only norovirus vaccine...

Norovirus is very expensive–A global economic burden of $60 billion

By

Norovirus. That nasty little bug most commonly associated with cruise ship outbreaks is quite costly, in medical, economic and societal terms. Norovirus kills 200,000 globally annually, while Bartsch...

Oral Norovirus Vaccine: Vaxart announces positive pre-clinical data

By

Vaxart, Inc., a privately held, clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced positive results demonstrating...

Norovirus vaccine study: Results indicate the vaccine ‘may be available in the future’: Researchers

By

Worldwide, noroviruses cause one in five cases of viral gastroenteritis and an estimated annual 300 million cases of norovirus infection contribute to roughly 260,000 deaths, mostly in low-income countries....